4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001209191-19-019755
President and CEO acquired 173,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Chang David D · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-13 | Grant or award : show line 1 in the form | +173,000 | 2,168,625 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-03-13 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +292,700 | 292,700 | D |
Loading xslF345X03/doc4.xml…